CVS HEALTH Corp (CVS)
Data as of , from SEC Form 4 filings.
See up to 3 months of CVS. The 7-day demo opens the 1M and 3M ranges and puts CVS on your watchlist.
Start 7-day demoLatest CVS insider trades
Larry RobbinsOpen-market sale$187.33M- Larry RobbinsOpen-market sale$34.62M
- Larry Robbins
About CVS HEALTH Corp (CVS)
CVS HEALTH Corp files with the SEC under CIK 0000064803 and is classified as drug stores and proprietary stores. It is grouped with Consumer Staples companies on this site.
CVS Form 4 activity by transaction type, last 90 days
No Form 4 activity for CVS in the last 90 days.
CVS insider transactions (Form 4)
5381 Form 4 filings on record, the earliest from Nov 25, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James David Clark - Officer | Tax withholding / forfeiture | Common Stock (Restricted) | 454 | $90.98 | $41K | |
| Brian Newman - Officer | Tax withholding / forfeiture | Common Stock | 2,478 | $90.98 | $225K | |
 Amy Compton-Phillips - Officer | Tax withholding / forfeiture | Common Stock | 7,618 | $90.98 | $693K | |
 Fernando Aguirre - Director | Derivative | Common Stock | 30,437 | $93.78 | $2.85M | |
| Fernando Aguirre - Director | Derivative | Common Stock | 1,563 | $93.50 | $146K | |
| Larry Robbins | Open-market sale | Common Stock | 1,983,387 | $94.45 footnote F2 | $187.33M | |
| Larry Robbins | Open-market sale | Common Stock | 370,462 | $93.45 footnote F9 | $34.62M | |
| Larry Robbins | Open-market sale | Common Stock | 151 | $95.18 | $14K | |
| Larry Robbins | Open-market sale | Common Stock | 797,628 | $93.48 footnote F5 | $74.56M | |
| Larry Robbins | Open-market sale | Common Stock | 152,691 | $94.81 footnote F6 | $14.48M | |
| Larry Robbins | Open-market sale | Common Stock | 66,881 | $95.67 footnote F7 | $6.40M | |
| Larry Robbins | Open-market sale | Common Stock | 800 | $96.28 footnote F8 | $77K | |
| Larry Robbins | Open-market sale | Cash-Settled Swaps | 378,000 | $93.31 | $35.27M | |
| ||||||
| John E. Gallina - Director | Grant or award | Deferred Stock Units | 1,448 | $97.15 | $141K | |
| Michael F. Mahoney - Director | Grant or award | Deferred Stock Units | 1,737 | $97.15 | $169K | |
| Fernando Aguirre - Director | Grant or award | Common Stock | 1,563 | $97.15 | $152K | |
| Jeffrey R. Balser - Director | Grant or award | Common Stock | 2,058 | $97.15 | $200K | |
 J. Scott Kirby - Director | Grant or award | Common Stock | 1,447 | $97.15 | $141K | |
| Leslie V. Norwalk - Director | Grant or award | Common Stock | 1,447 | $97.15 | $141K | |
| Guy P. Sansone - Director | Grant or award | Common Stock | 1,447 | $97.15 | $141K | |
| Alecia A. Decoudreaux - Director | Grant or award | Deferred Stock Units | 1,448 | $97.15 | $141K | |
| Anne A. Finucane - Director | Grant or award | Deferred Stock Units | 1,544 | $97.15 | $150K | |
| C. David Brown II - Director | Grant or award | Common Stock | 1,544 | $97.15 | $150K | |
 Douglas H. Shulman - Director | Grant or award | Deferred Stock Units | 1,448 | $97.15 | $141K | |
| Larry Robbins - Director | Grant or award | Deferred Stock Units | 1,930 | $97.15 | $187K | |
| Tilak Mandadi - Officer | Open-market sale | Common Stock | 69,551 | $89.58 footnote F1 | $6.23M | |
| ||||||
| Prem S. Shah - Officer | Grant or award | Common Stock (Restricted) | 25,062 | $71.82 | $1.80M | |
| Prem S. Shah - Officer | Tax withholding / forfeiture | Common Stock | 1,484 | $72.49 | $108K | |
| Prem S. Shah - Officer | Grant or award | Stock Option | 161,676 | $71.82 | $11.61M | |
| Brian Newman - Officer | Grant or award | Common Stock (RSUs) | 19,493 | $71.82 | $1.40M | |
| Brian Newman - Officer | Grant or award | Stock Option | 125,748 | $71.82 | $9.03M | |
| Steven H. Nelson - Officer | Grant or award | Common Stock (Restricted) | 22,277 | $71.82 | $1.60M | |
| Steven H. Nelson - Officer | Tax withholding / forfeiture | Common Stock | 2,432 | $72.49 | $176K | |
| Steven H. Nelson - Officer | Grant or award | Stock Option | 143,712 | $71.82 | $10.32M | |
| Tilak Mandadi - Officer | Grant or award | Common Stock (RSUs) | 22,277 | $71.82 | $1.60M | |
| Tilak Mandadi - Officer | Tax withholding / forfeiture | Common Stock | 3,634 | $72.49 | $263K | |
| Tilak Mandadi - Officer | Grant or award | Stock Option | 143,712 | $71.82 | $10.32M | |
| Samrat S. Khichi - Officer | Grant or award | Common Stock (Restricted) | 12,531 | $71.82 | $900K | |
| Samrat S. Khichi - Officer | Tax withholding / forfeiture | Common Stock | 3,541 | $72.49 | $257K | |
| Samrat S. Khichi - Officer | Grant or award | Stock Option | 80,838 | $71.82 | $5.81M | |
| J. David Joyner - Officer | Grant or award | Common Stock (RSUs) | 86,326 | $71.82 | $6.20M | |
| J. David Joyner - Officer | Tax withholding / forfeiture | Common Stock | 8,029 | $72.49 | $582K | |
| Amy Compton-Phillips - Officer | Grant or award | Common Stock (RSUs) | 5,569 | $71.82 | $400K | |
| Amy Compton-Phillips - Officer | Grant or award | Stock Option | 35,928 | $71.82 | $2.58M | |
| James David Clark - Officer | Grant or award | Common Stock (Restricted) | 11,138 | $71.82 | $800K | |
| James David Clark - Officer | Tax withholding / forfeiture | Common Stock | 3,262 | $72.49 | $236K | |
| James David Clark - Officer | Grant or award | Stock Option | 11,976 | $71.82 | $860K | |
| Heidi B. Capozzi - Officer | Grant or award | Common Stock (Restricted) | 10,025 | $71.82 | $720K | |
| Heidi B. Capozzi - Officer | Tax withholding / forfeiture | Common Stock | 1,334 | $72.49 | $97K | |
| Heidi B. Capozzi - Officer | Grant or award | Stock Option | 64,670 | $71.82 | $4.64M | |
| John E. Gallina - Director | Grant or award | Common Stock | 582 | $71.86 | $42K | |
| Samrat S. Khichi - Officer | Tax withholding / forfeiture | Common Stock | 7,886 footnote F1 | $79.60 | $628K | |
| ||||||
| J. David Joyner - Officer | Tax withholding / forfeiture | Common Stock | 1,944 footnote F1 | $79.90 | $155K | |
| ||||||
Item 5.02, 7.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07
Item 2.02, 9.01
Recent CVS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
Stock trades in CVS disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Dwight EvansDemocrat, PA-03 | Sale (partial) |
CVS insider trading FAQ
What is the latest insider trade for CVS?
CVS HEALTH Corp (CVS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-29. The full record for CVS runs to 81 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CVS stock?
No insider purchases of CVS were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling CVS stock?
No insider sales of CVS were filed in the last 90 days. 16 sales are on record for this company.
Where can I see CVS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CVS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James David Clark view on EDGAR
- - Brian Newman view on EDGAR
- - Amy Compton-Phillips view on EDGAR
- - Fernando Aguirre view on EDGAR
- - Larry Robbins view on EDGAR
- - John E. Gallina view on EDGAR
- - Michael F. Mahoney view on EDGAR
- - Fernando Aguirre view on EDGAR
- - Jeffrey R. Balser view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Consumer Staples
- Where CVS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CVS with a 7-day demo
- CVS on your watchlist
- Every CVS Form 4 filing on record
- Up to 3 months of CVS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
